×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

UK Pain Patch Market

ID: MRFR/HC/49538-HCR
200 Pages
MRFR Team
May 2025

UK Pain Patch Market Research Report: By Application (Chronic Pain Relief, Acute Pain Relief, Muscle Pain Relief, Joint Pain Relief, Post-operative Pain Relief), By Product Type (Heat Patch, Cold Patch, Medicated Patch, Herbal Patch, Transdermal Patch), By End User (Hospitals, Clinics, Home Care, Pharmacies, Sports Facilities) andBy Distribution Channel (Online, Offline, Pharmacies, Supermarkets, Specialty Stores)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Options

UK Pain Patch Market Summary

Industry Developments

The UK Pain Patch Market has witnessed several significant developments recently, reflecting the dynamic nature of this sector. In October 2023, Teva Pharmaceuticals launched a new formulation of its pain relief patch aimed at providing extended relief for chronic pain patients, responding to a growing demand for non-opioid options. Boehringer Ingelheim has also been involved in research partnerships to innovate pain management therapies that integrate patches with digital health solutions. Meanwhile, Haleon has reported a marked increase in sales driven by its over-the-counter pain patch range. In August 2023, Endo International confirmed its strategy to enhance its product line in the pain management domain, eyeing a merger with a smaller biotech firm to expand its market reach in the UK. Regulatory bodies are increasingly reviewing pain management products to ensure efficacy and safety, influencing growth patterns across companies like Mylan and AstraZeneca, which are actively working on improving their product formulations. The overall market valuation in the UK has seen a surge attributed to a growing acceptance of pain patches among healthcare professionals and patients alike, shaping a more competitive landscape in recent years.

Report Scope

Report Scope:
Report Attribute/Metric Source:Details
MARKET SIZE 2018413.6(USD Million)
MARKET SIZE 2024450.0(USD Million)
MARKET SIZE 2035860.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 6.065% (2025 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
MARKET FORECAST PERIOD2025 - 2035
HISTORICAL DATA2019 - 2024
MARKET FORECAST UNITSUSD Million
KEY COMPANIES PROFILEDTeva Pharmaceuticals, Boehringer Ingelheim, Haleon, Regeneron Pharmaceuticals, Endo International, Fresenius Kabi, Mylan, Hikma Pharmaceuticals, AstraZeneca, GSK, Purdue Pharma, Johnson & Johnson, AbbVie, Novartis, Norgine
SEGMENTS COVEREDApplication, Product Type, End User, Distribution Channel
KEY MARKET OPPORTUNITIESGrowing demand for non-invasive solutions, Increasing prevalence of chronic pain, Rising awareness of pain management options, Technological advancements in patch delivery, Expanding elderly population needing pain relief
KEY MARKET DYNAMICSincreasing chronic pain prevalence, rising demand for non-invasive treatments, aging population driving market growth, advancements in drug delivery technologies, regulatory approval processes impacting supply
COUNTRIES COVEREDUK

Leave a Comment

FAQs

What is the expected market size of the UK Pain Patch Market in 2024?

The UK Pain Patch Market is expected to be valued at 450.0 million USD in 2024.

What is the projected market value for the UK Pain Patch Market by 2035?

The market is expected to reach an estimated value of 860.0 million USD by the year 2035.

What is the projected compound annual growth rate (CAGR) for the UK Pain Patch Market from 2025 to 2035?

The CAGR for the UK Pain Patch Market is anticipated to be 6.065 percent from 2025 to 2035.

Which application segment holds the largest market share in the UK Pain Patch Market in 2024?

Chronic Pain Relief is the largest segment, valued at 180.0 million USD in 2024.

What is the expected market value for Acute Pain Relief in the UK Pain Patch Market by 2035?

The market value for Acute Pain Relief is expected to reach 180.0 million USD by 2035.

Who are the key players in the UK Pain Patch Market?

Major players include Teva Pharmaceuticals, Boehringer Ingelheim, Haleon, Regeneron Pharmaceuticals, and Endo International.

How is the market for Muscle Pain Relief expected to grow by 2035?

The market for Muscle Pain Relief is expected to increase to 130.0 million USD by 2035.

What are the market value projections for Post-operative Pain Relief by 2035?

Post-operative Pain Relief is projected to reach a market value of 70.0 million USD by 2035.

What challenges might affect the growth of the UK Pain Patch Market?

Challenges may include regulatory hurdles and competition from alternative pain management solutions.

What growth drivers are influencing the UK Pain Patch Market from 2025 to 2035?

Key growth drivers include increasing demand for effective pain relief solutions and advancements in patch technologies.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions